ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Transmembrane Transporters >P-gp modulators >ZOSUQUIDAR TRIHYSROCHLORIDE

ZOSUQUIDAR TRIHYSROCHLORIDE

ZOSUQUIDAR TRIHYSROCHLORIDE Structure
CAS No.
167465-36-3
Chemical Name:
ZOSUQUIDAR TRIHYSROCHLORIDE
Synonyms
LY335979;Trihydrochloride;CS-58;D06387;RS 33295-198;LY335979) 3HCl;Zosuquidar HCl;Zosuquidr.3HCl;Zosuquidar 3HCl;Zosuquidar TriHCl
CBNumber:
CB81482979
Molecular Formula:
C32H32ClF2N3O2
Molecular Weight:
564.07
MOL File:
167465-36-3.mol
MSDS File:
SDS
Modify Date:
2023/6/30 15:45:59

ZOSUQUIDAR TRIHYSROCHLORIDE Properties

Melting point 172-176°C
storage temp. Inert atmosphere,Room Temperature
solubility Methanol (Slightly), Water (Slightly, Sonicated)
form Solid
color Pale Yellow to Light Yellow

ZOSUQUIDAR TRIHYSROCHLORIDE Chemical Properties,Uses,Production

Chemical Properties

Pale Yellow Solid

Uses

Multi-drug resistance (MDR) modulator; selective inhibitor of P-glycoprotein (P-gp). Antineoplastic adjunct (chemosensitizer).

ZOSUQUIDAR TRIHYSROCHLORIDE Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 139)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CHEMSWORTH +91-261-2397244 New Delhi, India 6707 30 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29826 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 26216 58 Inquiry
Dayang Chem (Hangzhou) Co.,Ltd. 571-88938639 +8617705817739 China 52861 58 Inquiry

ZOSUQUIDAR TRIHYSROCHLORIDE Spectrum

Zosuquidar 3HCl Zosuquidar trihydrochloride, >=98% RS 33295-198 LY335979 (Zosuquidar 3HCl) ZOSUQUIDAR TRIHYSROCHLORIDE LY335979, RS 33295-198 Zosuquidar Trihydrochloride [6(R)-(1aα,6α,10bα)]-4-(1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl)-α-[(5-quinolinyloxy)Methyl]-piperazineethanol trihydrochloride, (2R)-anti-5-{3-[4-(10,11-difluoroMethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy RS-33295-198, ZOSUQUIDAR (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)Methyl]-1-piperazineethanol Hydrochloride LY335979 (Zosuquidar trihydrochloride) (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride Zosuquidar (LY335979 1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-,trihydrochloride RS 33295-198 (D06387) 3HCl (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride Zosuquidar trihydrochloride LY335979 Zosuquidar trihydrochloride LY335979 Zosuquidr.3HCl(LY335979) Zosuquidar (LY335979) 3HCl (αR)-4-[(1aα,6α,10bα)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol trihydrochloride RS-33295-198; ZOSUQUIDAR; LY-335979 CS-58 LY-335979 trihydrochloride RS 33295-198 trihydrochloride Zosuquidar TriHCl ZOSUQUIDAR TRIHYSROCHLORIDE USP/EP/BP 1-Piperazineethanol,4-[(1aa,6a,10ba)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-a-[(5-quinolinyloxy)methyl]-,hydrochloride (1:3), (aR)- LY335979) 3HCl Zosuquidar (RS 33295-198 Zosuquidar HCl Zosuquidr.3HCl (R)-1-(4-((1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl)piperazin-1-yl)-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride LY 335979; LY-335979; LY335979; D06387; RS33295198; D06387 Zosuquidar (LY335979) triHydrochloride LY335979 Trihydrochloride Zosuquidar trihydrochloride 3HCL CEM/VLB100,Pgp,2780AD,Multidrug resistance protein 1,CD243,anti-tumor activity,P388/ADR,P-glycoprotein,UCLA-P3.003VLB,2780,ABCB1,MCF7,acute myelogenous leukemia,MDR1,HL60,P-gp,UCLA-P3,P388,MCF7/ADR,CCRF-CEM,K562,Inhibitor,Zosuquidar trihydrochloride,Cluster of differentiation 243,AML,inhibit LY335979(Zosuquidar)/Zosuquidar trihydrochloride, RS-33295-198 4-piperazin-1-ylpyrrolidin-2-one 1-(3-aminocyclopentyl)-N,N-dimethyl-pyrrolidin-3-amine Levodropropizine Impurity 12 N'-(3-pyridylmethyl)butane-1,4-diamine methyl (4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-[4-(3-pyridylmethylamino)butylamino]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate 167465-36-3 C32H31F2N3O23HCl C32H34Cl3F2N3O2 C32H31F2N3O23ClH Inhibitors Aromatics Chiral Reagents Heterocycles Intermediates & Fine Chemicals Pharmaceuticals